Anti-AKR7A2 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | AKR7A2 |
| Immunogen: | This antibody is produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding to Aflatoxin B1 aldehyde reductase member 2. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000); Immunocytochemistry (1:200) |
| Reactivity: | Human, Mouse, Rat |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Protein A/G affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | AFAR antibody |
| AFAR1 antibody | |
| AFB1 aldehyde reductase 1 antibody | |
| AFB1 AR1 antibody | |
| AFB1-AR 1 antibody | |
| AFB1AR1 antibody | |
| Aflatoxin aldehyde reductase antibody | |
| Aflatoxin B1 aldehyde reductase member 2 antibody | |
| Aflatoxin beta1 aldehyde reductase antibody |
Show More
Target information
Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Provider
Erpantech Laboratory
